GHR and hepatocellular carcinoma: To further validate the impact of sorafenib on GHR expression in HCC cell lines, the mRNA level of GHR was increased in different HCC cell lines including HepG2, Huh7, QGC7701 and SMMC7721 cells treated with 5 μM or 10 μM sorafenib.